Literature DB >> 8024739

Immunopathological patterns in the rectal mucosa of patients with shigellosis: expression of HLA-DR antigens and T-lymphocyte subsets.

R Raqib1, F P Reinholt, P K Bardhan, A Kärnell, A A Lindberg.   

Abstract

Expression of HLA-DR antigens and infiltration of T-lymphocyte subsets (CD4, CD8), cell activation marker (CD25), B cells (CD20), macrophages (CD68 and Ber-Mac 3) and natural killer cells (CD56) in the rectal mucosa of patients with bacillary dysentery and in healthy controls were studied in an effort to interpret the immunopathological changes taking place in the rectal mucosa during the acute phase of shigellosis. The epithelium of the rectal mucosa from 21 of 32 patients was HLA-DR+. Conventional histology showed acute inflammation in 16 of these patients, chronic inflammation in 3, and in 2 histology was normal. In 7 of 20 controls the epithelium was HLA-DR+; 4 of these 7 were found to suffer from chronic inflammation, whilst in 3 the mucosa was normal. The number of HLA-DR+ intraepithelial lymphocytes in biopsies from patients with Shigella infection was significantly higher (p = 0.005) than in controls. The infiltration of CD8+ cells in the surface epithelium and in the lamina propria, and of CD4+ cells in the lamina propria alone, was significantly higher (p < 0.001) in patients than in controls. The results demonstrate that infiltration of T cells with suppressor/cytotoxic or helper/inducer phenotype in the epithelium and in the lamina propria in Shigella-infected patients may be related to the induction of HLA-DR expression in non-lymphoid cells during acute Shigella infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024739     DOI: 10.1111/j.1699-0463.1994.tb04886.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  10 in total

1.  Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Joydeep Mukherjee
Journal:  Mol Cell Biochem       Date:  2009-11-14       Impact factor: 3.396

2.  Persistence of mucosal mast cells and eosinophils in Shigella-infected children.

Authors:  Rubhana Raqib; Pricila Khan Moly; Protim Sarker; Firdausi Qadri; Nurul Haque Alam; Minnie Mathan; Jan Andersson
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Innate immune responses in children and adults with Shigellosis.

Authors:  R Raqib; S M Mia; F Qadri; T I Alam; N H Alam; A K Chowdhury; M M Mathan; J Andersson
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2.

Authors:  Rubhana Raqib; Caroline Ekberg; Protim Sharkar; Pradip K Bardhan; Arturo Zychlinsky; Philippe J Sansonetti; Jan Andersson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.

Authors:  Rubhana Raqib; Protim Sarker; Peter Bergman; Gul Ara; Monica Lindh; David A Sack; K M Nasirul Islam; Gudmundur H Gudmundsson; Jan Andersson; Birgitta Agerberth
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-01       Impact factor: 11.205

6.  Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis.

Authors:  D Islam; B Wretlind; A A Lindberg; B Christensson
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

7.  Down-regulation of gamma interferon, tumor necrosis factor type I, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor beta type I receptors at the local site during the acute phase of Shigella infection.

Authors:  R Raqib; A A Lindberg; L Björk; P K Bardhan; B Wretlind; U Andersson; J Andersson
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

8.  T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans.

Authors:  Franklin R Toapanta; Paula J Bernal; Karen L Kotloff; Myron M Levine; Marcelo B Sztein
Journal:  J Transl Med       Date:  2018-03-13       Impact factor: 5.531

9.  Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Rubhana Raqib; Protim Sarker; Akhirunnesa Mily; Nur Haque Alam; Abu Saleh Mohammed Arifuzzaman; Rokeya Sultana Rekha; Jan Andersson; Gudmundur H Gudmundsson; Alejandro Cravioto; Birgitta Agerberth
Journal:  BMC Infect Dis       Date:  2012-05-10       Impact factor: 3.090

10.  Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers.

Authors:  Ian Teo; Steve M Toms; Benoit Marteyn; Teresa S Barata; Peter Simpson; Karen A Johnston; Pamela Schnupf; Andrea Puhar; Tracey Bell; Chris Tang; Mire Zloh; Steve Matthews; Phillip M Rendle; Philippe J Sansonetti; Sunil Shaunak
Journal:  EMBO Mol Med       Date:  2012-08-06       Impact factor: 12.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.